Systematic review / meta-analysis / 2020
DHEA supplementation significantly increased serum IGF-1 levels, particularly in women and individuals over 60 years old.
A systematic review and meta-analysis of 24 randomized controlled trials was conducted to evaluate the effect of DHEA supplementation on serum IGF-1 levels. Overall, DHEA significantly increased serum IGF-1 compared to control (WMD: 16.36 ng/ml, 95% CI: 8.99, 23.74; p = .000). Subgroup analyses showed significant increases in women (WMD: 23.30 ng/ml, 95% CI: 13.75, 32.87), those receiving 50 mg/d DHEA (WMD: 15.75 ng/ml, 95% CI: 7.61, 23.89), interventions >12 weeks (WMD: 17.2 ng/ml, 95% CI: 8.02, 26.22), individuals without comorbidities (WMD: 19.11 ng/ml, 95% CI: 10.69, 27.53), and participants aged over 60 years (WMD: 19.79 ng/ml, 95% CI: 9.86, 29.72).
- Study type
- Dose-response meta-analysis of randomized controlled trials
- Who was studied
- Participants across 24 qualified randomized controlled trials
- What was measured
- Serum levels of insulin-like growth factor 1 (IGF-1)
THE PAPER
Impact of dehydroepianrosterone (DHEA) supplementation on serum levels of insulin-like growth factor 1 (IGF-1): A dose-response meta-analysis of randomized controlled trials.
Xie M, Zhong Y, Xue Q, Wu M, Deng X, O Santos H, Tan SC, Kord-Varkaneh H, Jiao P. Exp Gerontol, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.